-
Apr 24, 2026Non-GLP Pharmacology Studies For Regulatory Submission: Data Integrity & Labo...Learn how non-GLP pharmacology studies can support regulatory submissions through ALCOA+ data integrity, controlled laboratory practices, and translational NHP models from Prisy... -
Apr 20, 2026Strategic Design Of Nonclinical Pharmacokinetic Studies: From ADME Profiling ...Learn how to design robust nonclinical pharmacokinetic studies, including ADME profiling, dose selection, and sampling strategies. Discover how Prisys Biotech supports translati... -
Mar 10, 2026Evaluating DMPK Properties Of Candidate Compounds in Early Drug Discovery | P...Learn how key pharmacokinetic parameters—including clearance, volume of distribution, half-life, oral bioavailability, and exposure—are used to evaluate DMPK properties of candi... -
Jan 13, 2026Blood Sampling Time Point Design in Pharmacokinetic (PK) Studies | Prisys Bio...Learn how to design robust blood sampling time points for pharmacokinetic studies. This guide explains regulatory principles, phase-specific sampling strategies, and practical P... -
Jan 09, 2026PK Statistics: Non-compartmental Analysis (NCA) Parameters And Preclinical Ap...A comprehensive guide to Non-compartmental Analysis (NCA) in pharmacokinetics. Learn about key PK parameters (AUC, Cmax, CL, Vz) and their significance in preclinical NHP studie... -
Jan 06, 2026Why Non-Human Primate Models Are Critical For CNS Oligonucleotide TherapeuticsExplore why non-human primate models are essential for translating CNS oligonucleotide therapeutics, from biodistribution heterogeneity to precision brain delivery and clinical ... -
Jan 04, 2026Uric Acid Metabolism in Humans Vs Monkeys: Translational Implications For Dru...Explore the evolutionary and metabolic differences in uric acid handling between humans and non-human primates, and how these differences impact translational drug development a... -
Nov 10, 2025RFP Template For NHP Studies | Accelerate Preclinical Research EfficiencyLearn how to prepare an effective Research Request for Proposal (RFP) for non-human primate (NHP) studies with Prisys Biotech. Our structured RFP template ensures rapid evaluati... -
Aug 26, 2025The Importance Of Administration Volume in Preclinical Studies | Prisys BiotechDiscover why administration volume is a critical factor in preclinical drug development. Learn how standardized dosing volumes improve safety, data reliability, and translationa... -
Aug 05, 2025Serum Vs. Plasma: Choosing The Optimal Matrix For Preclinical BioanalysisDiscover how to choose between serum and plasma for drug analysis in preclinical studies. Prisys Biotech explains the scientific and operational trade-offs critical to accurate,... -
Jul 31, 2025Preclinical Dosing Guidelines: IV & PO Volume, PH, And Osmolarity For Accurat...Ensure accuracy in preclinical PK studies with optimized IV and PO dosing volumes, pH, and osmolality across species. Learn how Prisys Biotech enhances drug delivery in NHP and ... -
Jul 10, 2025A Guide To Anti-Drug Antibody (ADA) AssessmentExplore ADA formation, risk factors, impact on PK/ADME, and advanced preclinical assessment strategies, including the TDAR assay offered by Prisys Biotech.
